Game-Changing Breast Cancer Drug Offers New Hope for Patients
Apr, 12 2025

Game-Changing Breast Cancer Drug Offers New Hope for Patients

Capivasertib, a new drug developed with UK expertise, has been approved by NHS in England for advanced breast cancer patients with specific genetic mutations. This targeted therapy, combined with hormone treatment, significantly extends progression-free survival and shrinks tumors in nearly a quarter of patients. Urgent genetic testing is essential to identify eligible patients, with appeals for Scotland to approve the drug.

Nationwide Recall Issued for Milka Chocolate Bars: Allergy Alert Due to Hidden Hazelnuts
Apr, 2 2025

Nationwide Recall Issued for Milka Chocolate Bars: Allergy Alert Due to Hidden Hazelnuts

The CFIA has issued a recall for Milka Bubbly Alpine Milk chocolate bars due to undeclared hazelnuts, posing a risk for individuals with nut allergies. Sold in several Canadian provinces, these bars have been linked to reports of allergic reactions. Consumers are advised to dispose of the product or seek refunds.

NHS England's Massive Central Staff Reduction Aims to Boost Frontline Care
Mar, 14 2025

NHS England's Massive Central Staff Reduction Aims to Boost Frontline Care

NHS England is set for a drastic reshaping, cutting 50% of its central workforce to reduce bureaucracy and allocate more resources to frontline healthcare. The overhaul follows a wave of leadership departures and a shift in control to the Department of Health, aiming for over £100 million in savings annually. There are concerns about potential impacts on staff morale and service delivery.

New HKU5 Coronavirus Strain Yet to Infect Humans, Thai Health Officials Confirm
Feb, 27 2025

New HKU5 Coronavirus Strain Yet to Infect Humans, Thai Health Officials Confirm

Thai officials confirm the HKU5-CoV-2 strain, identified in bats, has not yet affected humans. As a Merbecovirus subtype, it has unique ACE2 binding patterns hinting at animal-to-human transmission but currently poses no immediate threat. Health measures remain effective, and Thailand's vigilant surveillance continues, especially with ongoing concerns about the Omicron variant.